Global Community

MacroGenics is pushing ahead with several cancer drug trials that could unlock new treatments if the results hold up, and the next round of updates may reshape what investors expect from the business. But rising research spending and a limited cash runway mean the company may need a partner or new funding sooner than many realize.Read more

agilon health is betting on a growing wave of older patients and a broader shift toward doctors being rewarded for keeping people healthier, not for doing more procedures. But leadership upheaval and recent trouble controlling care costs raise the question of whether the company can turn that demand into steady profits.Read more

ClearView Wealth is betting that moving its life insurance business onto a single cloud platform will cut costs and help it grow faster, especially as Australia’s population ages and more people need retirement and protection products. But heavier claims, tighter rules around advisers, and weaker investment returns could make that growth harder to achieve.Read more

Americold sits in the middle of a growing need to store and move food safely, and could benefit as more companies outsource cold storage instead of building it themselves. But intense price competition, customers pulling work in-house, and a heavy debt load could limit how much of that demand turns into lasting profits.Read more

Oil India is betting big on a faster refinery expansion, new petrochemical products, and a push into cleaner energy as India’s fuel needs keep climbing. But the upside comes with real pitfalls, from swings in global oil prices to government limits and the risk that new projects take longer to pay off.Read more

IOL Chemicals and Pharmaceuticals pushes deeper into tightly regulated export markets and broadens its lineup beyond ibuprofen, aiming to become a steadier supplier for global drug makers. The upside depends on smoother approvals and reliable sourcing, while weak pricing and reliance on a few products could still squeeze profits.Read more

Praemium is gaining traction as financial advisers move toward more digital, automated tools, and its newer platform features are helping it keep clients and grow repeatable revenue. But big client departures, tougher competition, and the challenge of integrating past deals could still derail the profit story.Read more

Banque Saudi Fransi faces a squeeze as customers shift to more expensive deposits and new digital rivals chip away at traditional banking fees. The bigger question is whether its tech upgrades and push into wealth management can offset tougher competition and rising pressure on profits.Read more

International Seaways may look like a steady oil-shipping business today, but cleaner energy and tougher pollution rules could squeeze demand and raise costs over time. At the same time, a newer fleet, a strong balance sheet, and shifting trade routes could help it hold up better than bears expect.Read more